SLRX — SALARIUS PHARMACEUTICALS INC
SLRX (SALARIUS PHARMACEUTICALS INC) is tracked on HoldingsHub across five years of quarterly 13F filings. 14 funds have reported positions historically, with the sum of their latest reported stakes valued at $100.84K. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Millennium Management history | Q3 2022 | 115.68K | $23.00K | 0.00% | Reduce |
| Two Sigma Investments history | Q1 2023 | 10.37K | $19.81K | 0.00% | New |
| Citadel Advisors history | Q4 2023 | 24.48K | $15.67K | 0.00% | New |
| Geode Capital Management history | Q1 2024 | 24.77K | $13.09K | 0.00% | Hold |
| Northern Trust Corp history | Q3 2022 | 65.02K | $13.00K | 0.00% | Hold |
| Vanguard Group history | Q1 2024 | 14.56K | $7.70K | 0.00% | Hold |
| BNY Mellon history | Q3 2022 | 35.27K | $7.00K | 0.00% | Hold |
| JPMorgan Chase & Co history | Q2 2023 | 1.00K | $1.49K | 0.00% | New |
| Morgan Stanley history | Q1 2024 | 60 | $32 | 0.00% | Hold |
| Wells Fargo & Co history | Q1 2024 | 31 | $16 | 0.00% | Add |
| Renaissance Technologies history | Q1 2024 | 28.24K | $15 | 0.00% | Add |
| UBS Group AG history | Q1 2024 | 18 | $10 | 0.00% | Reduce |
| Bank of America Corp history | Q1 2024 | 16 | $8 | 0.00% | Hold |
| Fidelity Management & Research (FMR) history | Q1 2024 | 7 | $4 | 0.00% | Reduce |
New Positions (latest)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 14 funds)
| Fund | Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Geode Capital Management | — | — | 356.11K | 390.12K | 390.12K | 413.13K | 413.13K | 16.52K | 16.52K | 16.52K | 24.77K | 24.77K | 24.77K |
| Vanguard Group | 1.42M | 1.54M | 1.59M | 1.59M | 1.59M | 1.59M | 1.35M | 38.15K | 15.42K | 14.96K | 14.26K | 14.56K | 14.56K |
| Morgan Stanley | — | — | 759.77K | 1.50K | 1.50K | 1.50K | 1.50K | 63 | 60 | 220 | 220 | 60 | 60 |
| Wells Fargo & Co | — | — | 274 | 277 | 278 | 375 | 350 | 15 | 15 | 17 | 27 | 30 | 31 |
| Renaissance Technologies | — | — | — | 178.60K | 62.75K | 538.06K | 634.26K | 16.34K | 20.04K | 20.54K | 24.14K | 26.44K | 28.24K |
| UBS Group AG | — | — | 6.40K | 2.50K | 2.50K | 42.28K | 40.85K | 239 | 1.13K | 78 | 78 | 78 | 18 |
| Bank of America Corp | — | — | — | 26 | — | — | — | — | — | — | 32 | 16 | 16 |
| Fidelity Management & Research (FMR) | — | — | — | — | — | — | — | — | 47 | 1 | 49 | 33 | 7 |
| Citadel Advisors | — | — | — | — | — | 166.03K | — | — | — | — | — | 24.48K | — |
| JPMorgan Chase & Co | — | — | — | — | 2.86K | — | — | — | — | 1.00K | — | — | — |
| Two Sigma Investments | — | — | 19.32K | 90.47K | — | — | — | — | 10.37K | — | — | — | — |
| BNY Mellon | — | — | 35.51K | 35.51K | 35.51K | 35.27K | 35.27K | — | — | — | — | — | — |
| Millennium Management | — | — | 59.48K | 65.58K | 20.13K | 291.90K | 115.68K | — | — | — | — | — | — |
| Northern Trust Corp | — | — | 67.23K | 65.02K | 65.02K | 65.02K | 65.02K | — | — | — | — | — | — |